DFX Intelligence

Data Factory

Private creditBorrowerdrug discovery & developmentaunknown

BridgeBio Pharma, Inc

Private Credit

Search this name across graphsid dfx:pc:3c5ab2e3-a8f5-8d0e-2e0b-aaa8fe309d97

Data as of Sep 30, 2025 (this record's last observation) from The BDC tape; Adviser-reported credit funds; Deal parties; Pending. Page built Sep 19, 2026, 2:01 AM UTC and rebuilt at most every 15 minutes.

Relationships: 0
Dated events: 40
On other graphs: 1
Observed: Dec 31, 2022 to Sep 30, 2025
1 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

BridgeBio Pharma LLC

name equal multitoken · confidence 50% · family precision 100%

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Lenders: 11
BDCs: 1
Facilities: 3
Fair value, latest: $12.0M
First on a schedule: Dec 31, 2022
Last on a schedule: Sep 30, 2025

Facilities

one facility is one borrower, one kind and one lien; its size is the sum of the BDC pieces the tape can see, a lower bound, never the commitment

Kind	Lien	Size, lower bound	Fair value	Maturity	Maturity basis	Spread	PIK	Lenders	BDCs	Status	Last seen
Term loan	First lien	$300M	$299M	Jan 1, 2029	Html schedule	0	n/a	7	11	Unknown	Sep 30, 2024
other	unknown	n/a	n/a	n/a	n/a	n/a	n/a	1	1	Unknown	Dec 31, 2023
Common equity	equity	n/a	$12.0M	n/a	n/a	n/a	n/a	1	1	Unknown	Sep 30, 2025

Lenders holding it now

each BDC's own pieces on its latest schedule, folded to one row per lender; every amount is that BDC's piece as filed, so a sum is a lower bound

BDC	Pieces	Principal	Fair value	Unfunded	Nearest maturity	As of
Blue Owl Capital Corp III	1	$15.0M	$15.0M	$0	Jan 1, 2029	Sep 30, 2024

Relationships

No published relationship touches this entity yet.

Dated events

23 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Sep 30, 2024
Borrower left every BDC schedule
BridgeBio Pharma, Inc term loan (first lien) left every BDC schedule after 2024-09-30 (11 lenders, $300.0M last held)
BDC schedule of investments
$300M
Occurred
Sep 30, 2024
BDC left a facility
Blue Owl Technology Income Corp. no longer holds BridgeBio Pharma, Inc term loan after 2024-09-30; 1 BDC(s) still hold it
BDC schedule of investments
$10.5M
Occurred
Sep 30, 2024
BDC left a facility
Blue Owl Capital Corp II no longer holds BridgeBio Pharma, Inc term loan after 2024-09-30; 1 BDC(s) still hold it
BDC schedule of investments
$4.5M
Occurred
Sep 30, 2024
BDC left a facility
Blue Owl Capital Corp no longer holds BridgeBio Pharma, Inc term loan after 2024-09-30; 1 BDC(s) still hold it
BDC schedule of investments
$75.0M
Occurred
Sep 30, 2024
BDC left a facility
Blue Owl Technology Finance Corp. no longer holds BridgeBio Pharma, Inc term loan after 2024-09-30; 1 BDC(s) still hold it
BDC schedule of investments
$30.0M
Occurred
Sep 30, 2024
BDC left a facility
Blue Owl Technology Finance Corp. II no longer holds BridgeBio Pharma, Inc term loan after 2024-09-30; 1 BDC(s) still hold it
BDC schedule of investments
$30.0M
Occurred
Sep 30, 2024
BDC left a facility
Blue Owl Credit Income Corp. no longer holds BridgeBio Pharma, Inc term loan after 2024-09-30; 1 BDC(s) still hold it
BDC schedule of investments
$135M
Occurred
Mar 31, 2024
Maturity extended
BridgeBio Pharma, Inc term loan: maturity moved from 2026-11-17 to 2029-01-01
BDC schedule of investments
$225M
Occurred
Mar 31, 2024
Coupon changed
BridgeBio Pharma, Inc term loan: spread moved from 0.00% to 6.75%
BDC schedule of investments
$225M
Occurred
Mar 31, 2024
BDC joined a facility
Blue Owl Capital Corp II joins BridgeBio Pharma, Inc term loan (first lien) held by 10 other BDCs
BDC schedule of investments
$4.5M
Occurred
Mar 31, 2024
BDC joined a facility
Blue Owl Technology Finance Corp. joins BridgeBio Pharma, Inc term loan (first lien) held by 10 other BDCs
BDC schedule of investments
$30.0M
Occurred
Mar 31, 2024
BDC joined a facility
Blue Owl Credit Income Corp. joins BridgeBio Pharma, Inc term loan (first lien) held by 10 other BDCs
BDC schedule of investments
$135M
Occurred
Mar 31, 2024
BDC joined a facility
Blue Owl Technology Income Corp. joins BridgeBio Pharma, Inc term loan (first lien) held by 10 other BDCs
BDC schedule of investments
$10.5M
Occurred
Mar 31, 2024
BDC joined a facility
Blue Owl Technology Finance Corp. II joins BridgeBio Pharma, Inc term loan (first lien) held by 10 other BDCs
BDC schedule of investments
$30.0M
Occurred
Mar 31, 2024
BDC joined a facility
Blue Owl Capital Corp III joins BridgeBio Pharma, Inc term loan (first lien) held by 10 other BDCs
BDC schedule of investments
$15.0M
Occurred
Mar 31, 2024
BDC joined a facility
Blue Owl Capital Corp joins BridgeBio Pharma, Inc term loan (first lien) held by 10 other BDCs
BDC schedule of investments
$75.0M
Occurred
Dec 31, 2023
BDC left a facility
SLR Investment Corp. no longer holds BridgeBio Pharma, Inc term loan after 2023-12-31; 1 BDC(s) still hold it
BDC schedule of investments
$81.5M

Show 23 bookkeeping events

Occurred
Dec 31, 2025
Hercules Capital, Inc.: position exited in BridgeBio Pharma, Inc
Occurred
Dec 31, 2024
Blue Owl Technology Finance Corp.: position exited in BridgeBio Pharma, Inc ($30.0M principal)
Occurred
Dec 31, 2024
Blue Owl Credit Income Corp.: position exited in BridgeBio Pharma, Inc ($135.0M principal)
Occurred
Dec 31, 2024
Blue Owl Technology Income Corp.: position exited in BridgeBio Pharma, Inc ($10.5M principal)
Occurred
Dec 31, 2024
Blue Owl Capital Corp: position exited in BridgeBio Pharma, Inc ($75.0M principal)
Occurred
Dec 31, 2024
Blue Owl Capital Corp II: position exited in BridgeBio Pharma, Inc ($4.5M principal)
Occurred
Dec 31, 2024
Blue Owl Technology Finance Corp. II: position exited in BridgeBio Pharma, Inc ($30.0M principal)
Occurred
Sep 30, 2024
Blue Owl Capital Corp: principal increased in BridgeBio Pharma, Inc ($75.0M principal)
Occurred
Mar 31, 2024
SLR Investment Corp.: position exited in BridgeBio Pharma, Inc ($81.5M principal)
Occurred
Mar 31, 2024
Blue Owl Capital Corp III: new position in BridgeBio Pharma, Inc ($15.0M principal)
Occurred
Mar 31, 2024
Blue Owl Capital Corp: new position in BridgeBio Pharma, Inc ($.1M principal)
Occurred
Mar 31, 2024
Blue Owl Credit Income Corp.: new position in BridgeBio Pharma, Inc ($135.0M principal)
Occurred
Mar 31, 2024
SCP Private Credit Income BDC LLC: position exited in BridgeBio Pharma, Inc
Occurred
Mar 31, 2024
SLR HC BDC LLC: position exited in BridgeBio Pharma, Inc ($11.3M principal)
Occurred
Mar 31, 2024
Blue Owl Capital Corp II: new position in BridgeBio Pharma, Inc ($4.5M principal)
Occurred
Mar 31, 2024
Blue Owl Technology Income Corp.: new position in BridgeBio Pharma, Inc ($10.5M principal)
Occurred
Mar 31, 2024
Blue Owl Technology Finance Corp. II: new position in BridgeBio Pharma, Inc ($30.0M principal)
Occurred
Mar 31, 2024
Blue Owl Technology Finance Corp.: new position in BridgeBio Pharma, Inc ($30.0M principal)
Occurred
Mar 31, 2024
Hercules Capital, Inc.: position exited in BridgeBio Pharma, Inc ($76.3M principal)
Occurred
Dec 31, 2023
SLR HC BDC LLC: principal increased in BridgeBio Pharma, Inc ($11.3M principal)
Occurred
Dec 31, 2023
SCP Private Credit Income BDC LLC: position exited in BridgeBio Pharma, Inc ($14.7M principal)
Occurred
Dec 31, 2023
Hercules Capital, Inc.: principal increased in BridgeBio Pharma, Inc ($76.3M principal)
Occurred
Dec 31, 2023
SLR Investment Corp.: principal increased in BridgeBio Pharma, Inc ($81.5M principal)

Provenance

Graph: Private Credit
Canonical id: dfx:pc:3c5ab2e3-a8f5-8d0e-2e0b-aaa8fe309d97
First observed: Dec 31, 2022
Last observed: Sep 30, 2025 11 months ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

BridgeBio Pharma, Inc

Private Credit

Search this name across graphsid dfx:pc:3c5ab2e3-a8f5-8d0e-2e0b-aaa8fe309d97

Kind

Lien

Size, lower bound

Fair value

Maturity

Maturity basis

Spread

PIK

Lenders

BDCs

Status

Last seen

Term loan

First lien

$300M

$299M

Jan 1, 2029

Html schedule

n/a

Unknown

Sep 30, 2024

other

unknown

n/a

Unknown

Dec 31, 2023

Common equity

equity

n/a

$12.0M

n/a

Unknown

Sep 30, 2025

BDC

Pieces

Principal

Fair value

Unfunded

Nearest maturity

As of

Blue Owl Capital Corp III

$15.0M

Jan 1, 2029

Sep 30, 2024